Notices. Notice of public workshop; correction
265 words·~1 min read·
/register/2017/03/20/2017-05417·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 6345-03-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-0001] Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public workshop; correction. SUMMARY: The Food and Drug Administration
(FDA)is correcting a notice that appeared in the **Federal Register** of Thursday, December 29, 2016. The document announced a public workshop entitled “Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-based Products.” The document was published with an error in the Web site address to access the transcript of the workshop. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Monica Kapoor, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 3111C, Silver Spring, MD 20993, *CBERPublicEvents@fda.hhs.gov;* or Staci Revette, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 3109B, Silver Spring, MD 20993, *CBERPublicEvents@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: In the **Federal Register** of Thursday, December 29, 2016, in FR Doc. 2016-31628, on page 96008, the following correction is made: On page 96008, in the second column under the *Transcripts* caption of section III, *Participating in the Public Workshop,* the third sentence in the fourth paragraph is corrected to read, “Please be advised that as soon as a transcript of the public workshop is available, it will be accessible at: *http://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ucm525001.htm.* ” Dated: March 14, 2017. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2017-05417 Filed 3-17-17; 8:45 am]